Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ: MRNA )

38.50 +2.61 (+7.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
Ellison, Oracle's chairman, pointed to the use of AI to develop drugs like Moderna's cancer vaccine. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
These 3 Stocks Are Down to Start 2025. What's Going On?
Sonos, Moderna, and Shake Shack are all staring at some near-term headwinds – can they work through them? 
Via The Motley Fool
Moderna Unusual Options Activity For January 22
Via Benzinga
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Is Moderna Stock Trading Higher On Tuesday?
Moderna secures $590 million from HHS for mRNA flu vaccine development. 
Via Benzinga
Where Will Moderna Be in 3 Years?
Via The Motley Fool
Is Moderna Stock a Buy?
Via The Motley Fool
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
Via The Motley Fool
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. 
Via Benzinga
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump
In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older. 
Via Stocktwits
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
3M, Netflix And 3 Stocks To Watch Heading Into Tuesday
US stock futures trading higher on Tuesday. Stocks to watch: 3M, D.R. Horton, Moderna, United Airlines, Netflix. 
Via Benzinga
Is Moderna a Bad-News Buy for 2025?
Via The Motley Fool
Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?
Via The Motley Fool
Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
Via Benzinga
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,... 
Via Benzinga
These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Many stocks flashed buy signals as the major indexes rose to or above key levels. 
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Is Moderna Stock a No-Brainer Buy on the Sell-Off?
Via The Motley Fool
Moderna Stock Takes A 20% Hit
Moderna stock is now down close to 30% versus its YTD high. 
Via Talk Markets
Topics Stocks / Equities
Why Moderna Stock Just Crashed 21%
Via The Motley Fool
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns. 
Via Investor's Business Daily
Topics Government
Exposures Political
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be tested for the bird flu virus within 24 hours. 
Via Benzinga
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025. 
Via Investor's Business Daily
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
Via Benzinga
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken
The revised projection largely reflects declining COVID-19 vaccine demand, as fewer people seek boosters amid the ongoing shift to an endemic phase. 
Via Stocktwits
Exposures COVID-19
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
The company also had a setback for its CMV vaccine. 
Via Investor's Business Daily
Exposures COVID-19
Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives
Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.